Biomedical Waste Management - A Detailed Analysis
Author: LawSphereX
Category: General Law
Published:
Updated:
BIOMEDICAL WASTE MANAGEMENT: A DETAILED
ANALYSIS
Sreya Sree. M, Vellore Institute of Technology, Chennai Dr. Arun. D. Raj, Faculty, Vellore Institute of Technology, Chennai
ABSTRACT
Despite challenges emerging from rapid urbanization, growing healthcare infrastructure, and increased waste generation coupled with poor disposal systems, biomedical waste (BMW) management in India continues to be a matter of concern. Inadequate disposal of such waste has significant environmental and public health consequences. As the COVID-19 spread, it put additional pressure on the system with infectious waste such as masks, gloves and syringes from vaccines in need of proper disposal. This article studies the framework related to biomedical waste in India focusing on the Biomedical Waste Management Rules, 2016, and its amendments. The paper also analyzes important judicial interventions by the Supreme Court of India, High Courts and the National Green Tribunal (NGT) to ensure compliance.
About 774tons of BMW are generated across the India each day, with hospitals, clinics, and diagnostic centers contributing the most. While the disposal of biomedical waste through Common Biomedical Waste Treatment Facilities (CBWTFs) is mandated by regulatory agencies, systemic inefficiencies continues to exist, in the form of non-compliance in rural areas, unsafe handling of waste by waste pickers and inadequate infrastructure. These issues, when addressed, play a significant role in mitigating public health risks, environmental contamination, occupational hazards and promoting community health, ensuring that India achieves its optimum output in sustainable waste management. This article offers certain recommendations on potential policies to achieve sustainable management of biomedical waste during health emergencies.
Keywords: Biomedical waste, Biomedical Waste Management Rules, 2016, Common Biomedical Waste Treatment Facilities, COVID-19,
STATEMENT OF THE PROBLEM:
India's biomedical waste (BMW) management is an issue because of urbanization, growing healthcare, mounting waste and lack of awareness inadequate disposal. During The COVID-
19 pandemic, there was a manifold usage of biomedical materials to safeguard citizens, with
the need for safe disposal of infectious waste such as PPE, masks and syringes, which were made with non-biodegradable materials. The existing mechanisms are unable to cope with the huge amounts of BMW, with production reaching up to 774 tons per day, further the respective government didn’t have schemes to handle disposal. The inefficiencies comprise noncompliance in rural communities, unsafe waste handling by waste pickers, poor infrastructure, lack of statues for governing the issues. Fixing these are crucial for environmental safety, public health, and minimizing occupational risks, which conform to the sustainable waste management objectives.
SCOPE AND LIMITATION:
The research paper discusses the legal and functional framework of BMW in India. It engages in the examination of the Biomedical Waste Management Rules, 2016, and its amendments, which are the core regulatory framework. The scope also covers analyzing judicial interventions of the Supreme Court of India, High Courts, and the National Green Tribunal (NGT) to determine their effect on the enforcement and compliance of these rules. In addition, the paper discusses the challenges in biomedical waste management, trends, and provides recommendations for improvement. Although the paper gives a general overview of biomedical waste management in India, it has some limitations. It does not dwell in detail with the economic costs and financial implications of biomedical waste management systems.
Though it presents a brief comparison with other nations, it does not give a comprehensive comparative review of the world's biomedical waste management systems.
RESEARCH OBJECTIVE:
1) Examine the legal and regulatory regime for biomedical waste management in India, with
an emphasis on the Biomedical Waste Management Rules, 2016.
2) Evaluate the inadequacies and challenges in existing biomedical waste management
practices throughout the country.
3) Assess the impact and role of judicial interventions towards enhancing compliance and
enforcement of biomedical waste regulations.
4) Discuss the overall suggestions and strategies to improve the efficacy and sustainability of
biomedical waste management systems, especially in anticipation of future health emergencies.
RESEARCH QUESTION:
1) What are the key provisions and modifications of the Biomedical Waste Management Rules,
2016, and how do they capture the nuances of BWM?
2) What are the major challenges that affect the implementation of BMW in India,
encompassing infrastructural constraints and adherence concerns?
3) In what ways has the judiciary impacted enforcement and effectiveness of biomedical waste
management laws?
4) What are the most sustainable and feasible solutions that will enhance BMW in India to
better prepare for future pandemics, and improve the environment in general?
RESEARCH METHODOLOGY:
The methodology followed in this study includes doctrinal examination of the existing law on BMW, concentrating mostly on the Bio-medical Waste Management Rules, 2016, and the amended rules. The paper involves discussions on case laws and judgments as well as legal pronouncements from the Supreme Court, High Courts, and National Green Tribunal so as to decipher how the judiciary plays its part in evolving and implementing BMW control methods. Further, the research approach includes a literature review of peer-reviewed articles, reports, and organizational guidelines from organizations such as the WHO and CPCB to present a comprehensive picture of the issues and best practices in biomedical waste management.
LITERATURE REVIEW:
Healthcare waste management during the COVID-19 pandemic: A case study from India
(2021): This study analyzes the surge in biomedical waste in India during the COVID-19 pandemic. It highlighted the increased generation of PPE, masks, and other infectious waste, which overwhelmed existing waste management infrastructure. The research emphasized the need for improved segregation, collection, and treatment capacity to handle such crises and prevent environmental and health hazards. Biomedical waste management practices and knowledge among healthcare workers: A systematic review (2020): This paper reviews examined the knowledge, attitudes, and practices of healthcare workers regarding biomedical waste management. It identified gaps in knowledge and inadequate practices, such as improper segregation and handling of waste, which contribute to occupational risks and environmental pollution.
The review stressed the importance of training and education programs to improve healthcare workers' compliance with waste management protocols. Environmental assessment of biomedical waste incineration: A review (2019): This paper reviews the environmental impacts of biomedical waste incineration, a common treatment method. It discussed the release of air pollutants, including dioxins and furans, and their potential health risks. The review emphasized the need for advanced incineration technologies and emission control measures to minimize the environmental footprint of this treatment method.
INTRODUCTION:
According to the Bio-Medical Waste (Management & Handling) Rules 1998, Bio Medical waste is defined as any waste which is generated during the diagnosis, treatment or immunization of human beings or animals or in research activities pertaining thereto or in the production or testing of biological or in health camps. Biomedical waste management rules are meant to improve the proper segregation at source, transportation and disposal method to decrease the environmental pollution. 1 The Bio-Medical Waste (Management and Handling) Rules, 1998 was published vide notification number S. O. 630 (E) dated the 20th July, 1998, by the Government of India in the erstwhile Ministry of Environment and Forests, provided a regulatory frame work for 1 Guidelines for Management of Healthcare Waste Waste Management Rules, 2016 by Health Care Facilities, (June 25, 2018), https://cpcb. nic.
in/uploads/Projects/Bio-Medical-Waste/Guidelines_healthcare_June_2018. pdf.
management of bio-medical waste generated in the country; And whereas, to implement these rules more effectively and to improve the collection, segregation, processing, treatment and disposal of these bio-medical wastes in an environmentally sound management thereby, reducing the biomedical waste generation and its impact on the environment, the Central Government reviewed the existing rules; And whereas, in exercise of the powers conferred by sections 6, 8 and 25 of the Environment (Protection) Act, 1986 (29 of 1986), the Central Government published the draft rules in the Gazette vide number G. S. R. 450 (E), dated the 3rd June, 2015 inviting objections or suggestions from the public within sixty days from the date on which copies of the Gazette containing the said notification were made available to the public.
2 Biomedical waste is waste that is created during the course of diagnosing, treating, or immunizing either humans or animals or during diagnosing the patient or related works. It includes hazardous materials like used needles, contaminated dressings, pathological waste, expired pharmaceuticals, and chemical byproducts. Biomedical waste is different from normal day to day wastes and due to its infectious, toxic and harmful properties, it should be managed properly according to their priority. 3 Biomedical waste (BMW) refers to any waste generated during the diagnosis, treatment, or immunization of humans or animals, or in research activities related to these fields. It includes both infectious and non-infectious waste that may pose a risk to public health and the environment if not managed properly.
WHO defines medical waste as waste generated by health care activities, ranging from used needles and syringes to soiled dressings, body parts, diagnostic samples, blood, chemicals, pharmaceuticals, medical devices and radioactive materials. 4 Across the world, the expansion of healthcare services has led to a substantial increase in the challenges posed by biomedical waste management. For example, rapid urbanization, increasing medical tourism, and the growing healthcare infrastructure in developing nations like India have all contributed to a rapid increase in waste generation. Majority of infectious
2 https://vmmc-sjh.mohfw.gov.in/sites/default/files/BMW_RULES_2016.pdf
3 (Mar. 30, 2016), https://dhr.gov.in/sites/default/files/Bio-medical_Waste_Management_Rules_2016.pdf. 4 Biomedical Waste Management, https://mmcrgggh.tn.gov.in/ords/r/wsmmc/mmc12055555/biomedical-wastemanagement.
waste generated is from health care facilities which has increased even more during COVID - creating millions of tonnes of this waste for disposal from PPE, testing kits and vaccinations. The management of biomedical waste is considering segregation at source, safe collection, transportation, treatment, and final disposal. Incineration, autoclaving, chemical treatment, and advanced techniques such as plasma pyrolysis are among the commonly accepted processes internationally. But these solutions are challenged by barriers like poor infrastructure, the unawareness of healthcare workers, and weak enforcement of regulations. Responding to these challenges is important not just to prevent the spread of disease, but also to protect the health and safety of those who handle waste, health care workers and the environment from longer-term effects.
With the world at a moving towards sustainable development goals, the solutions catered to the challenges of biomedical waste management will remain an important for idealistic health systems and a better environment.
CHAPTER 1:
WASTE
There isn't one single definition of what waste is. "Waste" is defined under Section 3 (38)5 of the Hazardous and Other Wastes (Management & Transboundary Movement) Rules, 2016 as: “materials that are not products or by-products, for which the generator has no further use for the purposes of production, transformation or consumption.”6 Types of waste: Biomedical waste is categorized based on its source, type, and potential hazard. The World Health Organization (WHO) and the Biomedical Waste Management Rules, 2016 classify it into the following types: 7 • Infectious waste: waste known or suspected to contain pathogens and pose a risk of disease transmission, e.g. waste and waste water contaminated with blood and other body fluids, including highly infectious waste such as laboratory cultures and
5 https://hspcb.org.in/uploads/laws/hsm1.pdf.
6 Section 3(38) of The Hazardous and Other Wastes (Management and Transboundary Movement) Rules, 2016 7 Health-care waste, (Feb. 8, 2018), https://www.who.int/news-room/fact-sheets/detail/health-care-waste.
microbiological stocks; and waste including excreta and other materials that have been in contact with patients infected with highly infectious diseases in isolation wards; • Pathological waste: human tissues, organs or fluids, body parts, fetuses, unused blood products and contaminated animal carcasses; • Sharps waste: used or unused sharps, e. g. hypodermic, intravenous or other needles; auto-disable syringes; syringes with attached needles; infusion sets; scalpels; pipettes; knives; blades; broken glass; • Chemical waste: for example, solvents and reagents used for laboratory preparations, disinfectants, sterilants and heavy metals contained in medical devices (e. g. mercury in broken thermometers) and batteries; • Pharmaceutical and cytotoxic waste: pharmaceuticals that are expired or no longer needed; items contaminated by, or containing, pharmaceuticals.
Cytotoxic waste containing substances with genotoxic properties, e. g. waste containing cytostatic drugs (often used in cancer therapy); genotoxic chemicals; • Radioactive waste: such as products contaminated by radionuclides including radioactive diagnostic material or radio therapeutic materials; and • Non-hazardous or General waste: waste that does not pose any particular biological, chemical, radioactive or physical hazard. Health Care Facilities (HCFs)8 are primarily responsible for management of the healthcare waste generated within the facilities, including activities undertaken by them in the community. The health care facilities, while generating the waste are responsible for segregation, collection, in-house transportation, pre-treatment of waste and storage of waste, before such waste is collected by Common Bio-medical Waste Treatment Facility (CBWTF) Operator.
Thus, for proper management of the waste in the healthcare facilities the technical requirements of waste handling are needed to be understood and practiced by each category of the staff in accordance with the BMWM Rules, 2016. Waste generated from the healthcare facility is classified as:
8 Swathi Satish, Biomedical Waste Management, ClearIAS (June 23, 2023),
https://www.clearias.com/biomedical-waste-management/.
Bio Medical Waste • General Waste • Other Wastes Biomedical waste: Biomedical Waste Management Rules, 2016 in schedule 1 part 19 categorizes the bio-medical waste generated from the health care facility into four categories based on the segregation pathway and color code: • Yellow Category • Red Category • White Category • Blue Category The major sources of health-care waste or biomedical waste are: • hospitals and other health facilities • laboratories and research centres • mortuary and autopsy centres • animal research and testing laboratories • blood banks and collection services • nursing homes for the elderly. General waste: The general waste consists of all the waste other than bio-medical waste which has not been in
9 Schedule 1 Part 1 Biomedical Waste Management Rules, 2016
contact with any hazardous or infectious, chemical, or biological secretions and does not include any waste sharps. This waste consists of mainly: • Newspaper, paper, and card boxes (dry waste) • Plastic water bottles (dry waste) • Aluminum cans of soft drinks (dry waste) • Packaging materials (dry waste) • Food Containers after emptying residual food (dry waste) • Organic / Bio-degradable waste – mostly food waste (wet waste) • Construction and Demolition wastes These general wastes are further classified as dry wastes and wet wastes and should be collected separately. Such waste is required to be handled as per Solid Waste Management Rules, 2016, and Construction & Demolition Waste Management Rules, 2016, as applicable.
Other wastes: Other wastes consist of used electronic wastes, used batteries, and radio-active wastes which are not covered under biomedical wastes but have to be disposed of as and when such wastes are generated as per the provisions laid down under E-Waste (Management) Rules, 2016, Batteries (Management & Handling) Rules, 2001, and Rules/guidelines under Atomic Energy Act, 1962 respectively.
CHAPTER 2:
IMPORTANCE OF BIOMEDICAL WASTE MANAGEMENT:
Biomedical waste management is essential for protecting public health, ensuring
environmental protection and legal compliance in India's rapidly growing healthcare sector.
1. Prevention of Disease Transmission and Public Health Protection:
Rule 4(1) of BMWM Rules 201610 requires that all health-care facilities should segregate the waste at the source of generation with distinctive color-coding (Yellow/Red/White/Blue bins) to avoid cross-contamination. WHO estimates that 16 billion injections are given annually across the world, but 20% are improperly discarded. In 2011, An outbreak of hepatitis B in Gujarat, was caused by improper syringe and medical waste disposal, infecting 60 individuals. This shows how poorly managed BMW can become a carrier for blood borne diseases such as HIV, hepatitis B/C, and antimicrobial-resistant pathogens, etc.
2. Occupational Safety of Healthcare and Sanitation Workers:
Occupational Safety and Health Administration (OSHA) standards, adopted under India's Factories Act, mandate PPE for waste handlers. The PIL in B.L. Wadehra vs. Union of India11 resulted in Supreme Court directives on proper BMW handling after discovering medical waste was being mixed with municipal garbage in Delhi. A 2022 NHRC report revealed 32% of sanitation workers in Delhi hospitals had needle-stick
injuries caused by poor segregation. A Delhi waste handler died from sepsis which was caused due to a needle-stick injury after
exposure to Sharps improperly discarded in 2018. The WHO approximates that 16 billion injections take place worldwide on a yearly basis, yet much of these needles is not safely disposed.
10 Rule 4(1) of BMWM Rules 2016
11 1996 SCC (2) 594
3. Environmental Protection:
Schedule II of BMW Rules12 specifies emission standards for incinerators (e.g., particulate matter untreated hospital effluents.
4. Legal and Penalties for Non-Compliance:
The Vellore Citizens Welfare Forum vs. Union of India13 formulated the "Polluter Pays" principle, holding healthcare facilities responsible for environmental degradation due to improper waste disposal. It introduced the "Polluter Pays" principle for medical waste. In 2022, Tamil Nadu PCB levied ₹8.6 lakh fines on 104 hospitals for BMW violations, for sharps disposal in an improper manner. In 2023, TNPCB penalized Apollo Hospitals ₹5 lakh for mixing COVID-19 waste with general trash.
5. Pandemic Preparedness:
India's daily BMW production jumped from 619 tons, pre-pandemic to 1,014 tons in May 2021 peak, with Delhi alone producing 349% additional COVID-19 waste. The 2023 BMW Rules amendment added specific guidelines for pandemic waste disposal.
6. International Obligations:
India's compliance with the Basel Convention on hazardous waste is ensured through provisions such as Rule 12(1) of the BMWM Rules, prohibiting import of biomedical waste without CPCB consent.
12 Schedule II of BMWM Rules 2016
13 AIR 1996 SUPREME COURT 2715
JCI-accredited hospitals, such as Fortis use block chain-monitored waste disposal to comply with global standards.
7. Economic Benefits:
The 2023 amendment of the BMW Management Rules, 2016 added Extended Producer Responsibility for syringe/PPE producers. Kerala's decentralized BMW system recorded 92% compliance by training local entrepreneurs to run autoclaves, generating green jobs while minimizing transport costs for rural clinics.
CHAPTER 3:
BIOMEDICAL WASTE TREATMENT
India has a strict, science-based biomedical waste treatment system that aims to eliminate health hazards while reducing environmental damage:
1. Segregation:
All hospitals, clinics, and laboratories are required to segregate waste at the source with colorcoded bins according to Rule 4(1) of BMW Rules 2016: • Yellow Bags: For infectious waste such as soiled bandages, cultures, and anatomical waste • Red Bags: Soiled plastics (IV tubes, gloves) • Blue/White Puncture-proof Containers: Needles, syringes, blades • Black Bins: General non-hazardous waste In 2019, a Mumbai hospital was fined ₹2 lakhs for commingling COVID-19 waste with general trash, showing segregation isn't a choice.
2. On-Site Storage:
Waste can't accumulate in perpetuity. Rule 5 requires:
Storage spaces to be labeled and closed • 48 hours of maximum storage for metro hospitals • 72 hours for smaller ones Example: A 2022 CPCB inspection revealed Delhi's Safdarjung Hospital breaking storage timelines, resulting in maggot-infested waste mounds.
3. Transportation:
Only authorized vehicles equipped with GPS tracking are allowed to carry BMW (Rule 7). However, according to a 2021 study, 40% of rural Punjab hospitals utilized open trucks, which led to spilling of the trash. The B.L. Wadehra case (1996) revealed for the first time how medical waste was illegally being disposed of with municipal garbage in Delhi.
4. Core Treatment Methods:
A. Incineration (For High-Risk Waste)
Utilized for: Anatomical waste, discarded medicines • Schedule II standards mandate: § 1200°C operating temperature § Dioxin emissions
A 2023 study by IIT Delhi discovered 60% of UP incinerators failed to meet emission
standards, emitting poisonous fumes.
B. Autoclaving (Steam Sterilization)
Used for: Infectious waste and microbiological cultures • Must reach 121°C for 60 minutes according to CPCB guidelines • Kerala's decentralized autoclave units cut transport costs by 70% for rural clinics.
C. Microwave Treatment
emerging technology using radiation to inactivate pathogens • Rule 5(IV) requires validation tests every 6 months
D. Deep Burial
It is permitted only in rural areas without CBWTFs and must be at least 10 feet deep with lime layers (Schedule V) • In 2022 NGT prohibited this process in Himachal due to groundwater pollution.
E. Plasma Pyrolysis (Cutting-Edge Solution)
It uses 5000°C plasma torches to vaporize the waste. • Pilot projects at AIIMS Delhi exhibit 99.9% pathogen annihilation. • costly but emission-free
5. Final Disposal
Treated plastic waste can be reused as construction material. Incinerator ash is sent to secure landfills. Rule 8(3): All CBWTFs have to provide SPCB with annual disposal reports Failure of the system: Bengaluru's Ramky Enviro plant was closed in 2023 for dumping untreated waste, revealing loopholes in monitoring. The Vellore Citizens case (1996) compelled TNPCB to audit all incinerators after detecting mercury emissions were beyond limits. The COVID-19 provided as a wakeup call. The pandemic hit the system when PPE waste rose 600% in Delhi, and the 2023 Rules amendment implemented mandatory on-site shredding of
PPE and Separate tracking for vaccination waste.
CHAPTER 4:
LEGAL FRAMEWORK RELATING TO BIOMEDICAL WASTE MANAGEMENT
INTERNATIONAL REGULATIONS:
India is a signatory to several international conventions that indirectly or directly relate to the management of hazardous wastes, including biomedical waste. • Basel Convention on the Control of Transboundary Movements of Hazardous Wastes and their Disposal (198914): This is the most comprehensive global environmental treaty on hazardous and other wastes. Its objectives are to protect human health and the environment against the adverse effects resulting from the generation, management, transboundary movements, and disposal of hazardous wastes. Biomedical waste, particularly clinical waste from healthcare facilities, falls under the scope of this convention. The convention emphasizes the principles of environmentally sound management, waste minimization, and the control of the transboundary movement of hazardous wastes, requiring prior informed consent for exports and imports.
15 • Stockholm Convention on Persistent Organic Pollutants (POPs) (2001)16: This international treaty aims to protect human health and the environment from persistent organic pollutants (POPs). POPs are toxic chemicals that can accumulate in the environment and in living organisms, causing harm. Medical waste incinerators can be a source of unintentional POPs like dioxins and furans. The convention promotes best available techniques and best environmental practices, to minimize the release of POPs, including from waste incineration. • Minamata Convention on Mercury (2013)17: This convention is an international
14 Basel Convention > The Convention > Overview,
https://www.basel.int/theconvention/overview/tabid/1271/default.aspx. Attention Required!, Cloudflare https://www.unep.org/resources/report/basel-convention-controltransboundary-movements-hazardous-wastes. 16 Stockholm Convention on Persistent Organic Pollutants, https://www.state.gov/key-topics-office-ofenvironmental-quality-and-transboundary-issues/stockholm-convention-on-persistent-organic-pollutants/. 17 Minamata Convention on Mercury, US EPA (Feb. 24, 2014), https://www.epa.gov/internationalcooperation/minamata-convention-mercury.
treaty to protect human health and the environment from the adverse effects of mercury. While not exclusively focused on biomedical waste, it addresses mercury-containing medical devices such as thermometers and blood pressure devices, aiming for their gradual elimination and the environmentally sound management of mercury waste. • WHO Guidelines18: The World Health Organization (WHO) provides international guidelines and best practices for the safe management of healthcare waste. Although not legally binding treaties, these guidelines are widely recognized and often influence national regulations and practices in member states, including India. They cover all aspects of healthcare waste management, from generation to disposal.
INDIAN LEGISLATIONS GOVERNING BMWM:
The primary legal instrument in India is the Bio-medical Waste Management Rules, 2016, enacted under the Environment (Protection) Act, 1986. • Environment (Protection) Act, 1986: This umbrella act provides the central government with the power to create rules for environmental protection, including the management of hazardous substances like biomedical waste. The Bio-medical Waste Management Rules, 2016 derive their authority from this act. • Bio-medical Waste Management Rules, 2016: These rules provide a detailed framework for the generation, collection, segregation, storage, transportation, treatment, and disposal of biomedical waste. • National Green Tribunal Act, 2010: This act established the National Green Tribunal (NGT) to handle cases related to environmental protection and conservation of forests and other natural resources.
The NGT can hear cases related to the improper management of biomedical waste and can issue orders for penalties and remediation Key features of the BMWM Rules include19: • The rules cover a wider range of healthcare activities, including vaccination camps,
18 Medical waste, (Feb. 21, 2025), https://www.who.int/india/health-topics/medical-waste.
19 https://data.vikaspedia.in/short/lc?k=tKp2ww9Slk5DOAJ2neuM0Q.
blood donation camps, and research activities. • BMW is classified into specific categories (e.g., human anatomical waste, animal waste, sharps, chemical waste, etc.) with a mandate for color-coded segregation at the source to facilitate appropriate treatment and disposal. • All healthcare facilities generating BMW and common biomedical waste treatment and disposal facilities (CBWTFs) must obtain authorization from the State Pollution Control Boards (SPCBs) or Pollution Control Committees (PCCs). • The rules prescribe different treatment methods for various categories of BMW, such as incineration, autoclaving, microwaving, chemical treatment, and deep burial (permitted only in specific rural areas). They emphasize environmentally sound disposal methods. • A bar code system for bags or containers containing BMW is mandatory for proper
tracking and monitoring of the waste from generation to final disposal. • Duties of Healthcare Facilities include ensuring proper segregation, storage, labelling, transportation, and treatment of BMW. They are also responsible for training their staff and conducting regular health check-ups and immunizations for workers handling BMW.
Operators of CBWTFs are responsible for the timely collection, transportation, treatment, and disposal of BMW from healthcare facilities. They also have a role in training healthcare workers on proper BMW management practices. • SPCBs and PCCs are responsible for monitoring the compliance of healthcare facilities and CBWTFs with the rules and for granting authorizations. State governments are mandated to ensure the implementation of these rules in all healthcare facilities. • The rules specify penalties for violations, which can include fines, imprisonment, or closure of the facility. • The rules mandated an elimination of the chlorinated plastic bags, gloves, and blood bags in medical applications.
All healthcare facilities are required to prepare and implement a Biomedical Waste Management Plan. • Each facility needs to designate a Biomedical Waste Management Officer responsible for ensuring compliance.
CHAPTER 5:
CHALLENGES IN BIOMEDICAL WASTE MANAGEMENT:
The handling of biomedical waste (BMW) has many challenges. These are spread over different stages, ranging from generation to ultimate disposal, and include various stakeholders. • Lack of Training and Awareness: Most of the healthcare personnel, patients, and even visitors are not aware and properly trained in the segregation of BMW in colorcoded bins as laid down under the BMWM Rules, 2016. Due to this, the different categories of waste are combined, increasing the complexity and danger in the whole management process. • Inadequate Infrastructure: Certain health institutions, particularly the small ones, lack proper numbers of color-coded containers or proper labels, preventing proper segregation. • Lack of Seriousness: the attitude of the staffs leads to the lack of proper management.
The staff lack motivation and seriousness, among other characters, to help prevent improper segregation of waste. • Limited Number of Common Biomedical Waste Treatment Facilities (CBWTFs) and their irregular geographical distribution: In most states, the number of permitted CBWTFs is too low to treat all the BMW produced, resulting in overloading and possible delays in treatment. Geographical distribution of CBWTFs is typically irregular, and in some regions there is insufficient access, particularly rural and far-off areas and the North-Eastern states and island groups. This causes health facilities to carry waste for lengthy distances, enhancing costs and risk. Even if there are CBWTFs
available, they could have capacity limitations because of the growing amount of BMW, especially following epidemics like the COVID-19 pandemic. • Technological Restrictions: Certain current treatment technologies are not environmentally friendly or efficient enough for all types of BMW. • Inadequate Use of Protective Gears: Sanitation workers and BMW handlers working within transportation may not properly use personal protective gear (PPE) like gloves, masks, goggles, and overalls, putting them at risk of infections and injuries. • Inadequate Storage and transportation: Storage of BMW on a temporary basis within healthcare institutions might not necessarily be in accordance with the recommended standards, resulting in possible leakage, offensive smells, and infection transfer risk.
The machines being used for carrying BMW can either not be customized for such uses or, where customized, carry risks of leakage and exposure upon transit. • Absence of Competent Operators: Incompetently trained people undertaking BMW handling across different levels might result in improper handling and further risks. Personnel employed for waste handling tend not to receive good training. • Irregular Inspection: Regulatory agencies such as (SPCBs) do not perform occasional or insufficient inspections of healthcare centers and CBWTFs, resulting in inadequate compliance. • Ineffective Enforcement Mechanisms: Even if non-compliance is found, the enforcement measures may be too lenient to discourage violation.
• Data Gaps: There is usually an inadequate and comprehensive data on the generation, treatment, and disposal of BMW, and hence it is challenging to evaluate the efficiency of management practices and areas for improvement. Data regarding liquid biomedical waste is especially scarce. • Lack of Coordination: Coordination among different stakeholders such as healthcare facilities, CBWTFs, SPCBs, and local authorities is necessary for effective BMW management, which is not always smooth.
High Treatment and Disposal Costs: Effective BMW treatment and disposal may be costly, particularly for small healthcare facilities with limited finances, which can result in their compromising or adopting unsafe methods. • Stigma and Social Issues: Waste handlers can be stigmatized and discriminated against, which impacts their morale and the quality of their work. • Challenges Specific to Certain Regions: The challenging terrain and logistical difficulties in hilly and remote regions can slow down the development of CBWTFs and the efficient transportation of BMW. The same logistical difficulties are present in island regions, complicating and increasing the cost of BMW management. • Increased Waste Generation: Public health crises such as the COVID-19 pandemic cause a rapid and large surge in BMW, such as PPE, masks, and other soiled materials, overwhelming current management systems.
These complex challenges can be addressed only through a collective effort including stricter regulation enforcement, greater investment in infrastructure and technology, better training and awareness campaigns for all stakeholders, enhanced monitoring and data management, more public awareness and community participation.
CHAPTER 6:
JUDICIAL INTERVENTIONS REGARDING BMWM
The Indian judiciary has been instrumental in framing and enforcing the legal regime for biomedical waste management (BMWM) through a series of Public Interest Litigations (PILs) and writ petitions. Sensing the possible danger to public health and the environment from the unscientific handling and disposal of BMW, the courts have intervened proactively to enforce compliance with the Bio-medical Waste Management Rules and to redress particular cases of mismanagement. Rahul Vijay Singh Chugh vs. State of Haryana & Others (2012)20: This case was before the Punjab and Haryana High Court. It specifically addressed the non-
20 AIR 2012 SUPREME COURT 2901
compliance with the Bio-Medical Waste (Management and Handling) Rules, 1998, in the state of Haryana. The petitioner highlighted the lack of proper infrastructure and equipment for the treatment of biomedical waste in various hospitals and healthcare facilities. The High Court took a serious view of the matter, noting the potential health hazards posed by the improper disposal of BMW. It observed the lack of adequate Common Biomedical Waste Treatment Facilities (CBWTFs) and the failure of healthcare institutions to adhere to the prescribed rules. The court issued a series of directions to the State of Haryana and the Haryana State Pollution Control Board (HSPCB), including: o Conducting a survey of all healthcare facilities to assess their compliance with the BMW Rules. o Ensuring the establishment of sufficient CBWTFs to cater to the BMW generated in the state.
o Directing healthcare facilities to install necessary treatment equipment or tie up with authorized CBWTFs. o Mandating the HSPCB to strictly monitor the implementation of the BMW Rules and take action against defaulting institutions. o Calling for public awareness campaigns regarding the proper segregation and disposal of biomedical waste. G. J. Multiclave (India) Pvt. Ltd. vs. The State of Telangana (2017)21: This case before the Andhra Pradesh High Court. It involved a dispute related to the authorization and operation of a (CBWTF). The specific facts were about the legal obligations between the CBWTF and the healthcare facilities, the court's observations reinforced the importance of a regulated system for BMW management.
21 AIRONLINE 2017 HYD 95
The court reiterated the responsibility of healthcare facilities to segregate their biomedical waste and hand it over to authorized CBWTFs for treatment and disposal. It also emphasized the role of CBWTFs in providing proper treatment services. M. C. Mehta vs. Union of India & Others (2020)22: During the COVID-19 pandemic, the Supreme Court took suo moto cognizance of the issue of improper disposal of COVID-19 related biomedical waste, particularly in Delhi. The court expressed concerns about the potential for the spread of infection due to the indiscriminate disposal of PPE kits, masks, and other contaminated materials. The Supreme Court highlighted the urgent need for strict adherence to the Bio-medical Waste Management Rules, 2016, and the specific guidelines issued by the Central Pollution Control Board (CPCB) for the management of COVID-19 waste.
The court noted reports of general waste being mixed with COVID-19 biomedical waste, posing a significant public health risk. The Supreme Court issued several directions to the Delhi government and concerned authorities, including: o Ensuring proper segregation of COVID-19 biomedical waste at the source using the color-coded system. o Strengthening the collection and transportation mechanisms for COVID-19 waste. o Ensuring adequate capacity of CBWTFs to handle the increased volume of BMW.
o Implementing the bar code system for tracking COVID-19 biomedical waste. o Conducting awareness campaigns to educate the public about the proper disposal of masks and gloves used by the general public. o Directing strict enforcement of the BMW Rules and CPCB guidelines.
22 AIRONLINE 2020 SC 684
National Green Tribunal (NGT): The National Green Tribunal (NGT) has been actively involved in monitoring the implementation of BMW rules across the country. It has taken up numerous cases based on petitions highlighting instances of non-compliance, pollution caused by improper disposal, and the lack of adequate infrastructure. NGT often directs state pollution control boards to submit action-taken reports, conduct site inspections, and take remedial measures against defaulting healthcare facilities and CBWTFs. It has also imposed environmental compensation on polluters for violations. The NGT has focused on issues such as the lack of proper treatment facilities in certain states, the illegal dumping of biomedical waste, the failure to maintain proper records, and the inadequate training of healthcare workers.
The NGT's continuous monitoring and proactive approach have created sustained pressure on authorities to improve BMW management practices and ensure compliance with environmental regulations. Shailesh Singh v. State of UP (2021)23: The National Green Tribunal (NGT) addressed the illegal operation of a biomedical waste incinerator in Sitapur, UP, which was running without proper approvals and emitting toxic pollutants, harming residents and the environment. The tribunal ordered the immediate shutdown of the facility, imposed a ₹10 lakh fine on the operator, and directed the UP Pollution Control Board to ensure proper waste disposal and health monitoring for affected locals.
The case underscored the need for stricter enforcement of biomedical waste rules, particularly regarding unauthorized incinerators, and reinforced accountability for private operators violating environmental safeguards under the Bio-Medical Waste Management Rules, 2016, and the Environmental Protection Act, 1986. This judgment became a key reference for holding polluters accountable and highlighted gaps in rural biomedical waste management, pushing for better compliance to prevent health and
23 CIVIL APPEAL NO. 734 OF 2021
ecological risks.
CHAPTER 7:
BIOMEDICAL WASTE MANAGEMENT IN OTHER COUNTRIES:
Biomedical waste management practices and regulations vary across the globe, with differing economic conditions, healthcare systems, and environmental priorities. Yet, most developed countries have strict legislation. United States: Medical waste management is largely dealt with at the state level, with some federal regulation. The 1988 Medical Waste Tracking Act established a precedent, but states have their own specific regulations on segregation, storage, transportation, treatment (incineration, autoclaving, and chemical disinfection), and disposal. The Environmental Protection Agency (EPA) does have a regulatory role in some areas, especially hazardous waste. European Union: The European Union has regulations, like the Waste Framework Directive, that define the overall scheme of waste disposal, including waste from healthcare activities.
The member countries generally have specific regulations that are particular to their needs in the country. Treatment for the wastes are mostly achieved by incineration with energy production and autoclaving. Minimization and green treatment approaches receive a large priority. China: China's waste management legal system adopts a hierarchical framework, with national legislation and regulations complemented by local regulations and environmental standards. Regulations address the classification, collection, storage, transportation, treatment, and disposal of medical waste. Incineration is one of the commonly applied treatment methods; more emphasis has been placed on the reinforcement of the management systems, especially following public health emergencies.
While it's challenging to definitively name one single country with the "best" BMWM due to varying healthcare systems and reporting standards, Sweden and Germany are often recognized for their highly efficient and environmentally conscious waste management systems, which extend to biomedical waste.
Sweden and Germany: Both nations have strict and well-enforced regulations regarding the segregation, collection, treatment, and disposal of biomedical waste. Germany's regime is supported by the Closed Substance Cycle and Waste Management Act, which focuses on waste prevention, recycling, reuse, and safe disposal. Germany’s KrWG (Circular Economy Act) enforces waste-to-energy plants. Sweden also has a strong legal regime with a defined waste hierarchy of prevention, reuse, recycling, energy recovery, and ultimately, disposal as a last resort. Sweden’s "Zero Waste" Policy mandates 100% incineration with energy recovery. Medical workers and waste personnel in these nations receive extensive training on correct BMWM procedures, resulting in improved segregation and management. They invest a lot in and apply advanced, environmentally friendly treatment technologies.
24 Waste is burned at elevated temperatures, and the heat released is utilized to generate electricity and district heating while reducing landfilling. Chemical Disinfections are applied to particular forms of liquid and solid waste. They possess well-established and regulated collection and transportation systems for segregated biomedical waste through specialized vehicles and trained staff. Both the nations place a lot of emphasis on minimizing waste at the source as well as on actively encouraging the recycling of non-hazardous parts of healthcare waste where appropriate. They possess strong systems of monitoring and tracking biomedical waste from generation to ultimate disposal, promoting accountability and areas for improvement.
Both, Autoclaving and Microwave Treatments are commonly applied to sterilize infectious waste prior to disposal, frequently eliminating the requirement for incineration of some types of waste. There is greater public awareness and responsibility for waste management in general, which indirectly contributes to improved practice in healthcare environments. Sweden recycles 99% of its waste, including non-hazardous BMW. Germany’s "Green Dot" system ensures proper 24https://www. hprc. org/a-medical-waste-recycling-best-practice-of-thenetherlands/#:~:text=In%20light%20of%20their%20achievements,to%20observe%20their%20waste%2Dhandling
disposal of medical packaging.25 UMC Utrecht in the Netherlands uses microwave technology to disinfect hazardous waste, converting it into a powdery form utilized in the concrete industry. The Netherlands' UMC Utrecht, recycles the majority of plastics and metals it generates as hospital waste.
CHAPTER 8:
CURRENT TRENDS WITH RESPECT TO BIOMEDICAL WASTE MANAGEMENT
Technological Advancements: There is an increasing focus on adopting advanced technologies for BMW treatment and management. Recently, in April 2025, India's first indigenous Automated Biomedical Waste Treatment Plant, named "Sṛjanam," was launched at AIIMS New Delhi. Developed by CSIR-NIIST, this rig can disinfect pathogenic biomedical waste without using incinerators and has a daily capacity of 400 kg. This technology aims to provide an eco-friendlier and efficient alternative to traditional methods. Market Growth: The India BMWM Market is projected to grow significantly. Valued at USD
2.32 Billion in 2024, it is expected to reach USD 3.53 Billion by 2030, with a CAGR of 7.11%.
This growth indicates increasing awareness and investment in proper BMW management infrastructure. Challenges Persist: Despite progress, challenges remain in ensuring complete segregation at the source, enhancing the capacity of treatment facilities to meet the increasing waste generation, and improving the monitoring and enforcement of the rules across all healthcare facilities. Environmental Concerns: The environmental impact of improper BMW disposal, including soil and water contamination and the release of harmful emissions from inadequate incineration, continues to be a concern. Efforts are ongoing to promote more sustainable and environmentally friendly treatment methods.
25 https://www.mdpi.com/2313-4321/9/5/82
CHAPTER 9:
RECOMMNEDATIONS:
With the difficulties in biomedical waste management (BMWM) in India, a multi-faceted approach is needed to introduce substantial changes. Regulatory Implementation and Enforcement Strengthening: The SPCBs and PCCs must regularly and strictly inspect all healthcare facilities (HCFs) and CBWTFs to ensure compliance with the Bio-medical Waste Management Rules, 2016, and amendments thereto. India should establish a digital platform for monitoring BMW generation, collection, treatment, and disposal in real time. This can involve GPS vehicle tracking, HCFs and CBWTFs' online reporting, and automated non-compliance alerts. India must enhance the severity of penalties (imprisonment, fines, and facility closure) for BMW rule violations to serve as an effective deterrent. Ensure consistent and unbiased enforcement of these penalties.
Adequate resources and training should be provided to SPCBs and PCCs to monitor and enforce BMW rules effectively. Technical skills, man power, and logistic support form part of it. Carrying out regular independent audits of the management of BMW in HCFs and CBWTFs to detect shortfalls and make suggestions for improvements must be there. Raising Awareness, Training, and Capacity Building: Comprehensive Training Programs need to be made mandatory for all healthcare worker categories (doctors, nurses, paramedics, sanitation workers), as well as waste workers at CBWTFs, on BMW segregation, handling, storage, transportation, treatment, and disposal practices. Training must be interactive and practical.
A nationwide public awareness campaigns should be initiated through mass media to enlighten the public at large about the hazards of unsafe BMW disposal, particularly from home healthcare waste (e. g. , used syringes, kits, etc). Incorporation of in-depth modules on BMW management into the curriculum of medical, nursing, paramedical, and environmental science programs. Organizing programs to include informal waste pickers in the formal BMW management system with adequate training, protective equipment, and health monitoring, or avoid their exposure to BMW altogether. Employing the use of online web pages, videos, and mobile applications for dissemination of information and training on BMW management. Continuous training and awareness programs for healthcare workers, sanitation staff, and the public are crucial for effective BMW management.
Enhancing Infrastructure and Technology: Encourage the development of additional CBWTFs, particularly in underserved areas such as rural districts, the North-East, and island states. Offer incentives and simplify the process of authorization for the installation of new facilities. Support and encourage upgrading existing CBWTFs with new and green treatment technologies like incineration with energy recovery, plasma gasification, and advanced autoclave systems. Incentivize and encourage the large hospitals and medical colleges to implement suitable on-site treatment technologies that minimize the burden on CBWTFs and transportation hazards. Investigate the viability of creating specialized treatment facilities for special categories of hazardous BMW, including cytotoxic drugs and radioactive wastes.
Provide access to leak-proof, properly labeled, and safety-equipped vehicles for BMW transportation. Require and oversee the provision of compliant and sufficient storage facilities within HCFs for segregated BMW, with proper ventilation, security, and spill containment arrangements. Encouraging Waste Minimization and Recycling: Induce HCFs to implement BMW generation minimization practices like using reusable devices where appropriate, optimizing drug inventory management to minimize pharmaceutical waste, and inducing telemedicine when suitable. Identify and encourage recycling of the non-hazardous portion of BMW following proper disinfection and sterilization, like certain plastics and metals, as per applicable regulations.
Encourage the usage of biodegradable and non-chlorinated plastic products within healthcare facilities for the reduction of the environmental footprint of plastic waste. Improving Monitoring and Data Management: Enforce the proper implementation and national usage of a strong barcoding and tracking system for BMW from creation to ultimate disposal. This will enhance responsibility and transparency. Establish standardized digital formats for HCFs and CBWTFs to submit BMW generation, treatment, and disposal information, allowing for enhanced analysis and decision-making. Develop a national registry to compile and analyze BMW management data throughout the nation, offering insights into trends, challenges, and best practices. Perform regular audits of data provided by HCFs and CBWTFs to check for accuracy and detect the discrepancies.
Enhancing Collaboration and Coordination: Ensure improved coordination among health departments, environment departments, SPCBs/PCCs, and local authorities to manage BMWs
effectively. Consider Public-Private Partnerships (PPP) models for setting up and running CBWTFs and installing advanced treatment technologies. Collaborate with non-governmental organizations (NGOs) and research institutions involved in waste management to benefit from their knowledge and encourage innovative solutions. Addressing Specific Challenges: Remote and Hilly Areas: Create decentralized BMW management models appropriate for remote and hilly regions, e. g. , smaller, localized treatment units or safe disposal mechanisms suitable for the environment. Offer financial and logistical assistance to these areas. Pandemic Preparedness: Establish detailed protocols and infrastructure for handling the surge in BMW during pandemics and health crises, including specified collection and treatment facilities for infectious waste.
Home Healthcare Waste: Establish clear guidelines and mechanisms for safe collection and disposal of BMW generated from home healthcare, possibly through specified collection points or tie-ups with authorized collectors. Financial Sustainability: Provide sufficient budgetary provisions at the state and national levels for BMW management infrastructure, training, and enforcement. Levy rightful user fees on BMW treatment services and make the larger polluting HCFs pay more of the costs, following the "polluter pays" principle. Pursue financing from national and external agencies for BMW improvement projects. Through these detailed recommendations, India can immensely enhance its biomedical waste management process, protecting the public health and environment more effectively. Ongoing monitoring, evaluation, and adjustments to these measures will be imperative for long-term success.
CONCLUSION:
Biomedical Waste Management in India is regulated by the Bio-Medical Waste Management Rules, 2016, to ensure the safe disposal of harmful waste generated from healthcare establishments. Even with regulation guidelines, issues such as improper segregation, lax enforcement, and infrastructure constraints prevail. Proper BMWM necessitates intensified
compliance, greater awareness among the public, and investment in treatment equipment. Enhanced policies and implementation of sustainable management practices are essential in reducing environmental and public health hazards of unhygienic waste disposal. India is struggling with biomedical waste management, in contrast to Sweden and Germany, which have robust systems. India can do better by implementing the EU-style policies and investing in waste-to-energy technology. The COVID-19 pandemic called out weaknesses in India's system. Though the 2016 Rules are in place, judicial intervention is required for enforcement. Future improvement depends on stronger infrastructure, stronger enforcement, and technology. Effective BMW management, through regulation and technologies such as incineration and tracking, is required for environmental and public health.
Essential improvements rely upon stricter rule enforcement, cost-effective rural solutions, and worker training.
BIBLIOGRAPHY:
1. Biomedical Waste Management Rules, 2016.
2. Environmental Protection Act, 1986
3. National Green Tribunal Act, 2010
4. CPCB Guidelines on COVID-19 Waste Management (2020).
5. WHO Report on Biomedical Waste during COVID-19 (2021).
6. Biomedical wastes: Definition, sources, classification, collection, segregation,
Treatment and disposal – Solid and Hazardous Waste Management 7. https://energy.vikaspedia.in/viewcontent/energy/environment/waste-management/biomedical-waste-management/bio-medical-waste-and-its-segregation?lgn=en
8. https://www.basel.int/theconvention/overview/tabid/1271/default.aspx
9. https://www.unep.org/resources/report/basel-convention-control-transboundarymovements-hazardous-wastes
10. https://www.mdpi.com/2313-4321/9/5/82
11. Basel Convention on the Control of Transboundary Movements of Hazardous Wastes
and their Disposal (1989)
12. Stockholm Convention on Persistent Organic Pollutants (POPs) (2001)
13. Minamata Convention on Mercury (2013)
14. World Health Organization (WHO) Guidelines
15. AIR 2012 SUPREME COURT 2901
16. AIRONLINE 2017 HYD 95
17. AIRONLINE 2020 SC 684
18. CIVIL APPEAL NO. 734 OF 2021